Lv62
1990 积分 2021-05-11 加入
Update on the treatment of cancer cachexia
3天前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
11天前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
11天前
已完结
Update on the treatment of cancer cachexia
15天前
已完结
Muscle wasting: emerging pathways and potential drug targets
15天前
已完结
Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus
17天前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
20天前
已完结
Current advancements in pharmacotherapy for cancer cachexia
1个月前
已完结
B cell-targeted therapies in systemic lupus erythematosus
1个月前
已完结
Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation
2个月前
已完结
皖公网安备34019202002308
